Related Experiment Video
Updated: Sep 18, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
[Sertraline-induced acute eosinophilic pneumonia: When a side effect becomes a clinical case]
L Brichard1, C Stavart2, J El Hayeck1
1Département de pédiatrie, CHU UCL Namur (site de Dinant), 5500 Dinant, Belgique.
Introduction:
Eosinophilic lung disease encompasses a group of diffuse pulmonary parenchymal diseases characterized by eosinophilic infiltration, either localized or associated with a systemic process. Acute eosinophilic pneumonia, a rare and severe form, is often confused with infectious pneumonia. Its main triggers include smoking, medication, and idiopathic causes. Cases reported in the literature link sertraline, a commonly prescribed antidepressant, to this condition.
Case Report:
A 15-year-old female patient was admitted to hospital for febrile dyspnea, cough, chest pain, and hypoxemia. Her medical history included treatment with sertraline and smoking. Thoracic imaging revealed bilateral infiltrates, and bronchoalveolar lavage showed significantly increased eosinophils. Discontinuation of sertraline and initiation of corticosteroid therapy led to clinical improvement.
Conclusions:
This case highlights the importance of quickly identifying the rare adverse effects of antidepressants, particularly sertraline-induced acute eosinophilic pneumonia. Special attention is required when prescribing off-label this antidepressant to adolescents, especially in a context of rising mental health disorders in this population.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Pneumonia III: Complications and Assessment
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

